Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Ghanaian Minister of Finance appointed Chairman of the Board of Governors of EBID
- The Board of Governors of EBID holds its 23rd Annual General Meeting
- Kenya’s central bank lifts decade-long ban, welcomes new banks
- Four smugglers caught in Kenya with prized ants
- Starlink gets approval in Somalia
- Africa loses $89 billion to illicit financial flows
- Stanbic cuts deal with Kenya’s DCI and stops further probe in controversial airline deal
- Rendez-vous, the quarterly newsletter of the ECOWAS Bank for Investment and Development